171 related articles for article (PubMed ID: 36280529)
1. Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma.
Midenberg E; Higgins MI; Schmeusser BN; Patil DH; Zaldumbide J; Martini DJ; Steele S; Williams M; Nabavizadeh R; Psutka SP; Ogan K; Bilen MA; Master VA
Urol Oncol; 2023 Jan; 41(1):50.e19-50.e26. PubMed ID: 36280529
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma.
Higgins MI; Martini DJ; Patil DH; Nabavizadeh R; Steele S; Williams M; Joshi SS; Narayan VM; Sekhar A; Psutka SP; Ogan K; Bilen MA; Master VA
Cancer; 2021 Jun; 127(12):1974-1983. PubMed ID: 33760232
[TBL] [Abstract][Full Text] [Related]
3. Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus.
Schmeusser BN; Midenberg E; Palacios AR; Ali AA; Patil DH; Higgins M; Nabavizadeh R; Croll B; Williams M; Sheehy J; Zheng B; Narayan VM; Joshi SS; Ogan K; Psutka SP; Bilen MA; Master VA
Clin Genitourin Cancer; 2023 Aug; 21(4):475-482.e4. PubMed ID: 37210313
[TBL] [Abstract][Full Text] [Related]
4. Association Between Sarcopenia and Survival of Patients with Organ-Confined Renal Cell Carcinoma after Radical Nephrectomy.
Lee J; Suh J; Song C; You D; Jeong IG; Hong B; Hong JH; Kim CS; Ahn H
Ann Surg Oncol; 2022 Apr; 29(4):2473-2479. PubMed ID: 34625877
[TBL] [Abstract][Full Text] [Related]
5. Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma.
Makino T; Izumi K; Iwamoto H; Kadomoto S; Mizokami A
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371699
[TBL] [Abstract][Full Text] [Related]
6. Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma.
Xue W; Zhang Y; Wang H; Zhang Y; Hu X
Front Immunol; 2021; 12():778746. PubMed ID: 34917092
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum low-density lipoprotein cholesterol is an independent prognostic factor in patients with renal cell carcinoma after nephrectomy.
Cui F; Zhou H; Lv D; Wen J; Gong Q; Rong Y; Kang Y; Jia M; Shuang W
Lipids Health Dis; 2023 Feb; 22(1):26. PubMed ID: 36814277
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of prognostic nutritional index in renal cell carcinomas.
Tang Y; Liang J; Liu Z; Zhang R; Zou Z; Wu K; Lu Y; Wei X
Medicine (Baltimore); 2021 Mar; 100(10):e25127. PubMed ID: 33725913
[TBL] [Abstract][Full Text] [Related]
9. Impact of perioperative blood transfusion on oncologic outcomes in patients with nonmetastatic renal cell carcinoma treated with curative nephrectomy: A retrospective analysis of a large, single-institutional cohort.
Seon DY; Kwak C; Kim HH; Ku JH; Kim HS
Investig Clin Urol; 2020 Mar; 61(2):136-145. PubMed ID: 32158964
[TBL] [Abstract][Full Text] [Related]
10. Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell Cancer.
Psutka SP; Boorjian SA; Moynagh MR; Schmit GD; Costello BA; Thompson RH; Stewart-Merrill SB; Lohse CM; Cheville JC; Leibovich BC; Tollefson MK
J Urol; 2016 Feb; 195(2):270-6. PubMed ID: 26292038
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia as a predictor of overall survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
Sharma P; Zargar-Shoshtari K; Caracciolo JT; Fishman M; Poch MA; Pow-Sang J; Sexton WJ; Spiess PE
Urol Oncol; 2015 Aug; 33(8):339.e17-23. PubMed ID: 26094169
[TBL] [Abstract][Full Text] [Related]
12. Influence of nutritional deficiency on prognosis of renal cell carcinoma (RCC).
Ko K; Park YH; Lee JW; Ku JH; Kwak C; Kim HH
BJU Int; 2013 Oct; 112(6):775-80. PubMed ID: 24028765
[TBL] [Abstract][Full Text] [Related]
13. The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes.
Albisinni S; Pretot D; Al Hajj Obeid W; Aoun F; Quackels T; Peltier A; Roumeguère T
Prog Urol; 2019; 29(8-9):423-431. PubMed ID: 31196826
[TBL] [Abstract][Full Text] [Related]
14. Albumin-to-Alkaline Phosphatase Ratio as a Novel Prognostic Factor in Patients Undergoing Nephrectomy for Non-Metastatic Renal Cell Carcinoma: Propensity Score Matching Analysis.
Won I; Shim SR; Kim SI; Kim SJ; Cho DS
Clin Genitourin Cancer; 2022 Jun; 20(3):e253-e262. PubMed ID: 35241381
[TBL] [Abstract][Full Text] [Related]
15. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
16. Hypoalbuminaemia is associated with mortality in patients undergoing cytoreductive nephrectomy.
Corcoran AT; Kaffenberger SD; Clark PE; Walton J; Handorf E; Piotrowski Z; Tomaszewski JJ; Ginzburg S; Mehrazin R; Plimack E; Chen DY; Smaldone MC; Uzzo RG; Morgan TM; Kutikov A
BJU Int; 2015 Sep; 116(3):351-7. PubMed ID: 25123843
[TBL] [Abstract][Full Text] [Related]
17. Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker.
Schmeusser BN; Biermann H; Nicaise EH; Ali AA; Patil DH; Midenberg E; Helman T; Armas-Phan M; Nabavizadeh R; Joshi SS; Narayan VM; Bilen MA; Psutka SP; Ogan K; Master VA
Oncologist; 2023 Dec; 28(12):e1219-e1229. PubMed ID: 37540787
[TBL] [Abstract][Full Text] [Related]
18. Pre-existing type 2 diabetes is an adverse prognostic factor in patients with renal cell carcinoma.
Yang H; Yin K; Wang Y; Xia M; Zhang R; Wang W; Chen J; Wang C; Shuang W
J Diabetes; 2019 Dec; 11(12):993-1001. PubMed ID: 31141620
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of the Glasgow Prognostic Score in renal cell carcinoma: a meta-analysis.
Shim SR; Kim SJ; Kim SI; Cho DS
World J Urol; 2017 May; 35(5):771-780. PubMed ID: 27665441
[TBL] [Abstract][Full Text] [Related]
20. Impact of sarcopenia on post-operative outcomes following nephrectomy and tumor thrombectomy for renal cell carcinoma with inferior vena cava thrombus.
Watanabe S; Ishihara H; Takagi T; Kondo T; Ishiyama R; Fukuda H; Yoshida K; Iizuka J; Kobayashi H; Ishida H; Tanabe K
Jpn J Clin Oncol; 2021 Apr; 51(5):819-825. PubMed ID: 33558883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]